Morocco has launched three new studies to deepen its response to tuberculosis, focusing on patient stigmatization, household costs, and zoonotic tuberculosis linked to Mycobacterium bovis. The initiative aims to better document and address gaps in the national TB control program.
The studies are part of Morocco's ongoing efforts to combat tuberculosis, which remains a public health challenge. According to the World Health Organization, Morocco reported an estimated 30,000 new TB cases in 2024, with a treatment success rate of around 85%.
One study will examine the social stigma faced by TB patients, which can hinder diagnosis and treatment adherence. Another will assess the financial burden on households, including direct and indirect costs. The third will investigate zoonotic tuberculosis, particularly from livestock, to understand its contribution to human cases.
These research projects are expected to provide evidence for policy adjustments and resource allocation. The Moroccan Ministry of Health has partnered with local and international institutions to conduct the studies, with results anticipated within two years.
